PFSCF - Prometic Life Sciences: An Update
Introduction
I have written eight articles covering Prometic Life Sciences (OTCQX:PFSCF) here on Seeking Alpha since August 2017. If I am to name my personal favorite, that would be my second article entitled 'Prometic Life Sciences: The True Underdog'.
Even though less than 2 years have gone by, much has changed for Prometic, most significantly the delay of their first BLA for Ryplazim in April 2018, and the sudden departure of their founder and long-time CEO, Mr. Pierre Laurin, in December 2018.
The stock performance over the past five years perhaps